Freestone Grove Partners LP

Position in BMY — Bristol Myers Squibb Co

CIK 2007591 San Francisco, CA

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,874,709

+$2,428,392 QoQ

Shares Held

84,601

+109.7% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#550

of 2,506 holders

Holding Since

Dec 2024

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Freestone Grove Partners LP holds $182,044,995 across 6 Drug Manufacturers - General names. BMY ranks #5 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	517,230	$131,360,903
2	BIIB	Biogen Inc.	83,853	$18,117,279
3	LLY	ELI LILLY & Co	13,442	$16,122,739
4	PFE	Pfizer Inc	335,530	$8,079,562
5	BMY	Bristol Myers Squibb Co This page	84,601	$4,874,709
6	MRK	Merck & Co., Inc.	27,158	$3,489,803

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,874,709	84,601	+109.7%	Shares	Sole	2026-08-14
2026-03-31	$2,446,317	40,335	+191.9%	Shares	Sole	2026-05-15
2025-03-31	$842,637	13,816	-10.7%	Shares	Sole	2025-05-15
2024-12-31	$874,870	15,468	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.